Prevalence and clinical implications of anti-drug antibody formation and serum drug levels among patients with IBD receiving anti-TNF therapy: A cross-sectional study

Prevalence and clinical implications of anti-drug antibody formation and serum drug levels among patients with IBD receiving anti-TNF therapy: A cross-sectional study

Background: The emergence of tumor necrosis factor inhibitors (anti-TNF) has considerably changed the management of inflammatory bowel disease (IBD) in patients who do not respond to traditional therapies. This study assesses the prevalence of anti-TNF drug levels (DLs) and antibodies (ATAbs) in pat...

Full description

Saved in:
Bibliographic Details
Main Authors: Ahmed Alghamdi, Mohammed Alahmari, Khulood Aljohani, Aisha Alanazi, Bashaar Al Ibrahim, Mishal Alshowair, Marwa Tawfik, Waleed Alghamdi, Salman Alanazi, Faisal Alzayed, Abdullah S Alghamdi, Abdullah Bawazir, Hussam Alhamidi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-03-01
Series:The Saudi Journal of Gastroenterology
Subjects:
anti-tnf
antibody formation
inflammatory bowel disease
loss of response
saudi arabia
Online Access:https://journals.lww.com/10.4103/sjg.sjg_245_24
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items